Literature DB >> 3985951

Interaction of rhodamine 123 with mitochondria isolated from drug-sensitive and -resistant Friend leukemia cells.

S Abou-Khalil, W H Abou-Khalil, L Planas, H Tapiero, T J Lampidis.   

Abstract

Mitochondria isolated from Friend leukemia cell lines sensitive (FS) and resistant (FR) to rhodamine 123 (Rho123), showed respiratory control and ADP/O ratios indicative of well-coupled oxidative phosphorylation activity. When Rho123 was added to mitochondria from both cell lines, respiratory State 4 increased. The increase was higher in mitochondria isolated from resistant than from sensitive cells. Respiratory State 3 was slightly more inhibited by Rho123 in resistant than in sensitive cell mitochondria (98 and 82% inhibition, respectively). While it is not clear how the uncoupling-like effects of Rho123 on State 4 contribute to cellular toxicity, our results indicate that differential cellular sensitivity to the drug does not correlate with inhibition of oxidative phosphorylation in mitochondria isolated from drug-sensitive and -resistant cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985951     DOI: 10.1016/s0006-291x(85)80049-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Methods for detection of mitochondrial and cellular reactive oxygen species.

Authors:  Sergey I Dikalov; David G Harrison
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

Review 2.  From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.

Authors:  Metin Kurtoglu; Theodore J Lampidis
Journal:  Mol Nutr Food Res       Date:  2009-01       Impact factor: 5.914

3.  Caspase-independent apoptosis in Friend's erythroleukemia cells: role of mitochondrial ATP synthesis impairment in relocation of apoptosis-inducing factor and endonuclease G.

Authors:  Marina Comelli; Nadia Genero; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2009-01-29       Impact factor: 2.945

4.  IF(1) distribution in HepG2 cells in relation to ecto-F(0)F (1)ATPsynthase and calmodulin.

Authors:  Stefania Contessi; Marina Comelli; Sara Cmet; Giovanna Lippe; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2007-09-13       Impact factor: 2.945

5.  Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function.

Authors:  Carlo Vascotto; Elena Bisetto; Mengxia Li; Leo A H Zeef; Chiara D'Ambrosio; Rossana Domenis; Marina Comelli; Daniela Delneri; Andrea Scaloni; Fabio Altieri; Irene Mavelli; Franco Quadrifoglio; Mark R Kelley; Gianluca Tell
Journal:  Mol Biol Cell       Date:  2011-08-24       Impact factor: 4.138

6.  Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.

Authors:  D Kessel; K Woodburn
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

7.  Iron chelators target both proliferating and quiescent cancer cells.

Authors:  Mårten Fryknäs; Xiaonan Zhang; Ulf Bremberg; Wojciech Senkowski; Maria Hägg Olofsson; Peter Brandt; Ingmar Persson; Padraig D'Arcy; Joachim Gullbo; Peter Nygren; Leoni Kunz Schughart; Stig Linder; Rolf Larsson
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

Review 8.  Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.

Authors:  Xiaonan Zhang; Angelo de Milito; Maria Hägg Olofsson; Joachim Gullbo; Padraig D'Arcy; Stig Linder
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

9.  Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.

Authors:  Xiaonan Zhang; Mårten Fryknäs; Emma Hernlund; Walid Fayad; Angelo De Milito; Maria Hägg Olofsson; Vladimir Gogvadze; Long Dang; Sven Påhlman; Leoni A Kunz Schughart; Linda Rickardson; Padraig D'Arcy; Joachim Gullbo; Peter Nygren; Rolf Larsson; Stig Linder
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.